Immunobridging Analysis of Pemivibart for the Treatment of COVID-19: A Therapeutic Gap for the Immune-Compromised Population Remains. (academic.oup.com)

Authors: Holmes A … Wingertzahn MA Journal: Open Forum Infectious Diseases Published: 2026-08-01 DOI: https://doi.org/10.1093/ofid/ofag168